Is Forteo Approved for Men with Osteoporosis?
Yes, Forteo (teriparatide) is FDA-approved for treating osteoporosis in men at high risk for fracture, including those with glucocorticoid-induced osteoporosis.[1][2] It works by stimulating bone formation through daily subcutaneous injections of synthetic parathyroid hormone, typically for up to 2 years.
How Does Forteo Work in Men?
Forteo mimics the body's parathyroid hormone to increase bone density, particularly in the spine and hip. Clinical trials showed men gained 5-9% in lumbar spine bone mineral density after 18-21 months, with similar fracture risk reduction as in women.[3][4] It's often used when bisphosphonates fail or aren't tolerated.
Who Qualifies for Forteo in Men?
Men eligible include those with confirmed osteoporosis (T-score ≤ -2.5), prior fragility fractures, or multiple risk factors like low testosterone or steroid use. It's not first-line; guidelines from the American Association of Clinical Endocrinologists recommend it for high-risk cases.[5] Bone density scans and fracture history guide eligibility.
What Are Common Side Effects in Men?
Dizziness, leg cramps, nausea, and injection-site reactions occur in 5-10% of users. Hypercalcemia affects about 2%. Black-box warning limits lifetime use to 2 years due to potential osteosarcoma risk from animal studies, though human cases are rare.[1][6] Men should monitor calcium levels and avoid if history of bone cancer or radiation.
How Does Forteo Compare to Other Osteoporosis Drugs for Men?
| Drug | Mechanism | Approval for Men | Key Difference from Forteo |
|-----|------------|-------------------|----------------------------|
| Prolia (denosumab) | Inhibits bone breakdown | Yes | Monthly injection; reduces vertebral fractures faster but may cause jaw necrosis. |
| Reclast (zoledronic acid) | Bisphosphonate | Yes | Annual IV; cheaper but gastrointestinal side effects common. |
| Tymlos (abaloparatide) | Similar PTH analog | Yes | Daily injection; potentially fewer hypercalcemia cases. |
Forteo excels in building bone versus just preserving it, but follow-up antiresorptive therapy (e.g., bisphosphonates) is needed post-treatment.[7]
Cost and Access for Men
A 28-day supply costs $3,000-$4,000 without insurance; patient assistance programs from Lilly cover copays for eligible men.[8] Generic unavailable due to patents expiring around 2025 in some markets—check DrugPatentWatch.com for updates.[9]
When Does Forteo's Patent Expire?
Key U.S. patents expired in 2019, but formulation patents extend protection to 2025-2026. No generics approved yet; biosimilar challenges ongoing.[9]
[1] FDA Label: Forteo (teriparatide). https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021318s057lbl.pdf
[2] NIH Osteoporosis Guidelines. https://www.niams.nih.gov/health-topics/osteoporosis/diagnosis-treatment-and-steps-to-take
[3] NEJM: Teriparatide for Men (2001). https://www.nejm.org/doi/full/10.1056/NEJM200101253440404
[4] J Clin Endocrinol Metab: Forteo in Men (2005). https://academic.oup.com/jcem/article/90/12/6395/2837374
[5] AACE Osteoporosis Guidelines (2020). https://www.aace.com/disease-state-resources/bone-and-parathyroid/clinical-practice-guidelines
[6] Forteo HCP Site. https://www.forteo.com
[7] Endocrine Society Guidelines. https://www.endocrine.org/clinical-practice-guidelines/osteoporosis-in-men
[8] Lilly Patient Assistance. https://www.lilly.com/assistance
[9] DrugPatentWatch: Forteo Patents. https://www.drugpatentwatch.com/p/tradename/FORTEO